Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia-Reference-Cited by-同舟云学术

Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia

Published:2005-04 Issue:4 Volume:11 Page:319-325
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Bernabeu-Wittel M.,Pichardo C.,García-Curiel A.,Pachón-Ibáñez M.E.,Ibáñez-Martínez J.,Jiménez-Mejías M.E.,Pachón J.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference38 articles.

1. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features;Bergogne‐Bérézin;Clin Microbiol Rev,1996

2. Survival of Acinetobacter baumannii on dry surfaces;Wendt;J Clin Microbiol,1997

3. Incidence risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients;Torres;Am Rev Respir Dis,1990

4. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis;Lortholary;Clin Infect Dis,1995

5. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features;Cisneros;Clin Infect Dis,1996

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotic–Drug Interactions in the Intensive Care Unit: A Literature Review;Antibiotics;2024-05-29

2. Contribution of different mechanisms to aminoglycoside resistance in clinical isolates of Acinetobacter baumannii;Microbial Pathogenesis;2023-09

3. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections;Clinical Infectious Diseases;2023-07-18

4. In Vitro and In Vivo Effect of Amikacin and Imipenem Combinations against Multidrug-Resistant E. coli;Tropical Medicine and Infectious Disease;2022-10-02

5. Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections;Clinical Infectious Diseases;2021-12-05